CALABRESI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 17.306
EU - Europa 13.342
AS - Asia 11.215
SA - Sud America 2.608
Continente sconosciuto - Info sul continente non disponibili 1.159
AF - Africa 318
OC - Oceania 15
Totale 45.963
Nazione #
US - Stati Uniti d'America 16.860
SG - Singapore 5.182
UA - Ucraina 2.304
IE - Irlanda 2.116
IT - Italia 2.100
BR - Brasile 2.040
RU - Federazione Russa 1.736
CN - Cina 1.489
VN - Vietnam 1.477
SE - Svezia 1.378
HK - Hong Kong 1.306
FR - Francia 954
DE - Germania 858
FI - Finlandia 635
GB - Regno Unito 421
KR - Corea 383
IN - India 228
CA - Canada 195
AR - Argentina 188
BD - Bangladesh 183
TR - Turchia 167
NL - Olanda 142
IQ - Iraq 124
MX - Messico 123
PL - Polonia 115
ID - Indonesia 97
ZA - Sudafrica 97
AT - Austria 85
CH - Svizzera 84
EC - Ecuador 83
JP - Giappone 83
PK - Pakistan 81
UZ - Uzbekistan 81
CO - Colombia 75
CZ - Repubblica Ceca 72
RO - Romania 72
VE - Venezuela 67
SA - Arabia Saudita 55
BE - Belgio 54
ES - Italia 54
MA - Marocco 49
CL - Cile 48
PY - Paraguay 35
LT - Lituania 31
GR - Grecia 30
LB - Libano 29
PH - Filippine 28
JM - Giamaica 27
PE - Perù 27
DZ - Algeria 26
KE - Kenya 26
TN - Tunisia 26
EG - Egitto 25
JO - Giordania 24
UY - Uruguay 24
MY - Malesia 23
EU - Europa 22
IL - Israele 21
KZ - Kazakistan 19
AZ - Azerbaigian 18
BO - Bolivia 18
AL - Albania 16
CR - Costa Rica 15
ET - Etiopia 15
AE - Emirati Arabi Uniti 14
NP - Nepal 12
OM - Oman 12
AU - Australia 11
DO - Repubblica Dominicana 11
GT - Guatemala 11
KG - Kirghizistan 11
NI - Nicaragua 11
PS - Palestinian Territory 11
TT - Trinidad e Tobago 10
BG - Bulgaria 9
PA - Panama 9
HN - Honduras 8
HU - Ungheria 8
RS - Serbia 8
TH - Thailandia 8
XK - ???statistics.table.value.countryCode.XK??? 8
CI - Costa d'Avorio 7
HR - Croazia 7
SN - Senegal 7
SY - Repubblica araba siriana 7
BA - Bosnia-Erzegovina 6
BY - Bielorussia 6
GE - Georgia 6
PT - Portogallo 6
TW - Taiwan 6
BB - Barbados 5
CG - Congo 5
MD - Moldavia 5
ME - Montenegro 5
MN - Mongolia 5
SC - Seychelles 5
SI - Slovenia 5
SV - El Salvador 5
AO - Angola 4
DK - Danimarca 4
Totale 44.744
Città #
Singapore 3.633
Chandler 2.392
Dublin 2.110
Hong Kong 1.294
San Jose 1.191
Jacksonville 1.147
San Mateo 1.146
Ashburn 950
Boardman 850
Santa Clara 700
Dong Ket 648
Moscow 582
Medford 537
Princeton 533
Perugia 519
Altamura 490
Lauterbourg 452
Wilmington 401
Lawrence 388
Seoul 377
Des Moines 370
Beijing 359
Andover 343
Ann Arbor 308
Ho Chi Minh City 282
Los Angeles 240
Munich 216
The Dalles 196
Piscataway 172
São Paulo 172
Hanoi 167
New York 148
Saint Petersburg 147
Frankfurt am Main 105
Helsinki 101
Norwalk 97
Milan 93
Turku 89
Rome 83
San Paolo di Civitate 83
Falls Church 78
Woodbridge 77
Tokyo 73
Izmir 70
Rio de Janeiro 70
Redmond 69
Shanghai 69
Warsaw 67
Montreal 61
Brooklyn 60
Orem 60
Phoenix 58
Atlanta 56
Houston 55
Brussels 53
Bucharest 53
Denver 52
London 51
Stockholm 51
Chennai 48
Johannesburg 48
Tashkent 48
Chicago 46
Dallas 46
Dearborn 45
Toronto 43
Baghdad 42
Brno 38
Columbus 38
Belo Horizonte 37
Haiphong 36
Mexico City 36
Boston 35
Nuremberg 34
San Francisco 34
Amsterdam 32
Buffalo 32
Curitiba 32
Redwood City 32
Brasília 31
Den Haag 29
Poplar 29
Manchester 28
Porto Alegre 28
Guayaquil 27
Quito 27
Seattle 27
Bologna 26
Da Nang 26
Campinas 25
Dhaka 25
Ankara 24
Charlotte 24
Council Bluffs 24
Falkenstein 24
Amman 23
Medellín 23
Guangzhou 22
Nairobi 22
Florence 21
Totale 26.611
Nome #
The validation of an Italian version of the Freezing of Gait Questionnaire 836
Alpha-Synuclein Produces Early Behavioral Alterations Via Striatal Cholinergic Synaptic Dysfunction by Interacting with GluN2D N-Methyl-D-Aspartate Receptor Subunit 219
CSF and blood biomarkers for Parkinson's disease 204
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration 175
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation 160
Aortic stiffness and pulse wave reflection in young subjects with migraine: A case-control study. 154
Synaptic plasticity and experimental autoimmune encephalomyelitis: implications for multiple sclerosis 152
Migraine-specific quality of life questionnaire and relapse of medication overuse headache 151
A critical role of NO/cGMP/PKG dependent pathway in hippocampalpost-ischemic LTP: modulation by zonisamide. 150
Time trends, frequency, characteristics and prognosis of short-duration transient global amnesia 147
Cyclic vomiting syndrome, migraine, and epilepsy: a common underlying disorder? 141
Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis 141
Microglial activation and the nitric oxide/cGMP/PKG pathway underlie enhanced neuronal vulnerability to mitochondrial dysfunction in experimental multiple sclerosis 141
Decreased NR2B Subunit Synaptic Levels Cause Impaired Long-Term Potentiation But Not Long-Term Depression 139
Brain arteriovenous malformations and seizures: an Italian study. 137
Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients 134
Acetyl-L-Carnitine selectively prevents post-ischemic LTP via a possible action on mitochondrial energy metabolism. 133
Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies 132
Hippocampal epileptogenesis in autoimmune encephalitis 132
Early detection of substantia nigra changes in Parkinson's disease: a magnetization transfer ratio (MTR) study 130
Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies 128
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis 128
c-Jun N-terminal Kinase regulates soluble Abeta oligomers and cognitive impairment in an AD mouse model. 127
A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression. 126
A2A Adenosine Receptor Antagonism Enhances Synaptic and Motor Effects of Cocaine via CB1 Cannabinoid Receptor Activation. 126
Clinical aspects and management of levodopa-induced dyskinesia. 126
A magnetization transfer study of mild and advanced Parkinson's disease. 126
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation 125
Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis 125
Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease 125
A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission. 125
Electrophysiology and pharmacology of striatal neuronal dysfunction induced by mitochondrial complex I inhibition. 124
Substantia nigra hyperechogenicity in essential tremor and Parkinson's disease: a longitudinal study 124
A novel ATP1A2 gene mutation in familial hemiplegic migraine and epilepsy. 122
Cerebrospinal fluid biomarkers in Parkinson disease. 122
Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission 122
Subthalamic nucleus lesion reverses motor abnormalities and striatal glutamatergic overactivity in experimental parkinsonism. 121
Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies. 121
Acute dystonia induced by the combination of midodrine and perphenazine. 121
Effects of central and peripheral inflammation on hippocampal synaptic plasticity 121
Cerebrospinal fluid lysosomal enzymes and α-synuclein in Parkinson's disease. 121
Dural arteriovenous fistulas and headache features: an observational study 121
Dopamine-dependent early synaptic and motor dysfunctions induced by a-synuclein in the nigrostriatal circuit 121
Performance of Aβ1-40, Aβ1-42, Total Tau, and Phosphorylated Tau as Predictors of Dementia in a Cohort of Patients with Mild Cognitive Impairment. 120
A2A adenosine receptor antagonists protect the striatum against rotenone-induced neurotoxicity 120
Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology 120
Low doses of Perampanel protect striatal and hippocampal neurons against in vitro ischemia by reversing the ischemia-induced alteration of AMPA receptor subunit composition 120
Phyto-oestrogens in the prophylaxis of menstrual migraine. 119
Abnormal cortical lysosomal β-hexosaminidase and β-galactosidase activity at post-synaptic sites during Alzheimer's disease progression 119
Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis 119
Plasticity and repair in the post-ischemic brain 119
A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication. 118
A combination of CSF Tau ratio and midsaggital midbrain-to-pons atrophy for the early diagnosis of progressive supranuclear palsy. 118
Diagnostic accuracy of Parkinson disease by Support Vector Machine (SVM) analysis of 123I-FP-CIT brain SPECT data: implications of putaminal findings and age 117
Visual pathway involvement in multiple sclerosis: Look straight in the eyes 117
Long-term potentiation and memory processes in the psychological works of Sigmund Freud and in the formation of neuropsychiatric symptoms. 116
Cell-type specificity of mGluR activation in striatal neuronal subtypes. 116
Pharmacological inhibition of the Na(+)/Ca(2+) exchanger enhances depolarizations induced by oxygen/glucose deprivation but not responses to excitatory amino acids in rat striatal neurons. 116
Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease: protocol for a systematic review and individual participant data meta-analysis 116
2017 revisions of McDonald criteria shorten the time to diagnosis of multiple sclerosis in clinically isolated syndromes 116
Persistent activation of microglia and NADPH drive hippocampal dysfunction in experimental multiple sclerosis 115
Epilepsy in hemiplegic migraine: Genetic mutations and clinical implications 115
Deficits of glutamate transmission in the striatum of experimental hemiballism. 114
Tissue plasminogen activator controls multiple forms of synaptic plasticity and memory. 114
Occipital arteriovenous malformations andmigraine. 114
Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias. 114
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease. 114
Endogenous 17β-estradiol is required for activity-dependent long-term potentiation in the striatum: interaction with the dopaminergic system 114
Bidirectional Synaptic Plasticity Is Driven by Sex Neurosteroids Targeting Estrogen and Androgen Receptors in Hippocampal CA1 Pyramidal Neurons 114
Antiepileptic drugs on calcium currents recorded from cortical and PAG neurons: therapeutic implications for migraine. 113
A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia. 113
Electrophysiological actions of zonisamide on striatal neurons: Selective neuroprotection against complex I mitochondrial dysfunction. 113
Critical role of calcitonin gene-related peptide receptors in cortical spreading depression. 113
Skin biopsy: a new diagnostic tool for autonomic dysfunctions in Parkinson's disease? 112
Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease. 112
Extracranial Venous Drainage Pattern in Multiple Sclerosis and Healthy Controls: Application of the 2011 Diagnostic Criteria for Chronic Cerebrospinal Venous Insufficiency 112
The Italian version of Cognitive Function Instrument (CFI) for tracking changes in healthy elderly: results at 1-year follow-up 112
Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum. 111
Stimulation of nitric oxide-cGMP pathway excites striatal cholinergic interneurons via protein kinase G activation. 111
ACh/dopamine crosstalk in motor control and reward: a crucial role for alpha 6-containing nicotinic receptors? 111
A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice. 111
Electrophysiology of sipatrigine: a lamotrigine derivative exhibiting neuroprotective effects. 110
Migraine with aura in the locker room: three case reports. 110
Lower urinary tract symptoms and urodynamic dysfunction in clinically isolated syndromes suggestive of multiple sclerosis 110
Changes of olfactory tract in Parkinson’s disease: a DTI tractography study 110
Developmental impaired Akt signaling in the Shank1 and Shank3 double knock-out mice 110
Modulation of gene expression following long-term synaptic depression in the striatum. 109
Cerebrospinal fluid beta-glucocerebrosidase activity is reduced in Dementia with Lewy Bodies. 109
Long term headache duration is a factor predicting nonresponse to detoxification and advice in medication overuse headache 109
Sodium valproate in migraine without aura and medication overuse headache: A randomized controlled trial. 109
T2*-weighted MRI values correlate with motor and cognitive dysfunction in Parkinson's disease 109
Differences in Extracellular Matrix Production and Basic Fibroblast Growth Factor Response in Skin Fibroblasts from Sporadic and Familial Alzheimer’s Disease 109
Pathological Synaptic Plasticity in the Striatum: Implications for Parkinson's Disease. 108
An abnormal striatal synaptic plasticity may account for the selective neuronal vulnerability in Huntington's disease. 108
Ischemic bilateral hippocampal dysfunction during transient global amnesia. 108
Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice. 107
Coordinate high-frequency pattern of stimulation and calcium levels control the induction of LTP in striatal cholinergic interneurons. 107
Deficits of glutamate transmission in the striatum of toxic and genetic models of Huntington's disease. 107
The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum 107
A 1H magnetic resonance spectroscopy study in patients with obstructive sleep apnea. 107
Totale 12.997
Categoria #
all - tutte 210.171
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 210.171


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.353 0 792 110 257 135 55 55 1.426 88 162 475 798
2022/20237.804 619 1.432 157 639 586 979 10 314 2.704 20 257 87
2023/20242.712 166 310 154 59 31 18 433 134 361 92 448 506
2024/20256.587 114 669 226 270 813 325 311 568 1.343 432 932 584
2025/202614.689 1.074 1.083 877 2.231 1.893 1.278 2.294 741 1.612 1.077 315 214
2026/2027761 355 406 0 0 0 0 0 0 0 0 0 0
Totale 45.963